2-NP-AMOZ

Catalog No.: 
ACNZYB515
CAS No.: 
183193-59-1
Molecular Formula: 
C15H18N4O5
Molecular Weight: 
334.33
2-NP-AMOZ structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$437.00InquiryInquiry
100mg97%$657.00InquiryInquiry
250mg97%$1112.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-NP-AMOZ
IUPAC Name(E)-5-(morpholinomethyl)-3-((2-nitrobenzylidene)amino)oxazolidin-2-one
Molecular FormulaC15H18N4O5
Molecular Weight334.33
SMILESO=C1OC(CN2CCOCC2)CN1/N=C/C3=CC=CC=C3[N+]([O-])=O
InChI KeyPCYAMVONOKWOLP-CXUHLZMHSA-N
Synonym5-(4-MorpholinylMethyl)-3-[[(2-nitrophenyl)Methylene]aMino]-;NP-AMOZ 2-;5-(4-Morpholinylmethyl)-3-[[(2-nitrophenyl)methylene]amino]-2-oxazolidinone;NPAMOZ;2-NP-AMOZ Solution, 100ppm;2-NP-AMOZ Solition in Methanol, 100μg/mL;2-Oxazolidinone, 5-(4-morpholinylmethyl)-3-[[(2-nitrophenyl)methylene]amino]-;2-NP-AMOZ in Methanol
CAS No.183193-59-1

Synthetic Route by SureRoute

1. ACNZYB515 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRLKI876 route compound structure diagram
    ACRLKI87643056-63-9In Stock
  2. Plus
  3. ACFIGE287 route compound structure diagram
    ACFIGE287552-89-6In Stock
  4. Then
  5. ACNZYB515 route product structure diagram
    ACNZYB515183193-59-1
Inquiry

2. ACNZYB515 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZYB515 route product structure diagram
    ACNZYB515183193-59-1
Inquiry

3. ACNZYB515 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZYB515 route product structure diagram
    ACNZYB515183193-59-1
Inquiry

Comments (0)